Serum Institute Seeks Emergency Use Approval For Covovax COVID-19 Vaccine For 12-17 Age Group
India.com News Desk | Feb 21, 2022, 7:29 PM IST
Covovax is manufactured by technology transfer from Novavax and is approved by the European Medicines Agency for conditional marketing authorisation. It has been granted emergency use listing by the World Health Organisation on December 17, 2021.











